Experienced in Primary Familial Brain Calcification

Christopher Kobylecki

Salford, ENG, GB 
Experienced in Primary Familial Brain Calcification
Salford, ENG, GB 
OverviewLocationsClinical Research

Overview

Christopher Kobylecki practices in Salford, United Kingdom. Mr. Kobylecki is rated as an Experienced expert by MediFind in the treatment of Primary Familial Brain Calcification. His top areas of expertise are Movement Disorders, Parkinson's Disease, Multiple System Atrophy, Gastrostomy, and Deep Brain Stimulation.

His clinical research consists of co-authoring 97 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Primary Familial Brain Calcification.

Gender
Male

Locations

Salford, ENG, United Kingdom
Other Locations
Manchester, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease: A Phase 3 Randomised, Double-blind Placebo-controlled Trial of Rivastigmine to Prevent Falls in Parkinson's Disease.
CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease: A Phase 3 Randomised, Double-blind Placebo-controlled Trial of Rivastigmine to Prevent Falls in Parkinson's Disease.
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Other, Drug
Study Drug: Rivastigmine Transdermal System
Study Phase: Phase 3

97 Total Publications

Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK.
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK.
Journal: BMJ open
Published: July 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kobylecki's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile